NEWARK, Del, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The global neurointerventional devices market is anticipated to reach a valuation of US$ 2.6 billion in 2023, driven by an increase in healthcare expenditure. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 4.7% between 2023 and 2033, and reaching a total valuation of approximately US$ 4.1 billion by 2033.
One of the major factors contributing to the growth of the neurointerventional devices market is the improved reimbursement policies for neurointerventional procedures, which can encourage healthcare providers to invest in these devices and offer them to patients, thus driving market growth.
Patients increasingly prefer minimally invasive procedures due to shorter recovery times, reduced pain, and lower risk of complications, which can boost the demand for neurointerventional devices. Continuous improvements in neuroimaging technologies, such as MRI and CT scans, enable more accurate diagnosis and treatment planning, creating opportunities for neurointerventional devices.
Request Your Sample Report for more insights into the Neurointerventional Devices Market!
The approval of new neurointerventional devices by regulatory authorities and the launch of innovative products can stimulate market growth by offering advanced treatment options. Medical tourism, particularly for neurointerventional procedures, can boost the market growth in regions known for their advanced healthcare facilities and expertise in neurosurgery. A shift towards patient-centric care models, where patients are actively involved in their treatment decisions, can lead to increased demand for neurointerventional devices that offer improved patient experiences and outcomes.
Innovations in biomaterials and coatings for neurointerventional devices can enhance their biocompatibility and reduce the risk of adverse reactions, leading to wider adoption. 3D printing technology allows for the customization of neurointerventional devices, catering to individual patient anatomies and needs, which can improve treatment efficacy.
Growing emphasis on preventive neurology and early intervention can create opportunities for neurointerventional devices that enable early diagnosis and treatment of neurological conditions. Investment in healthcare infrastructure, including the establishment of specialized neurointerventional centers, can expand the reach of these devices and services.
Key Takeaways from the Neurointerventional Devices Market Study
- Global neurointerventional devices market was valued at US$ 2.5 billion by 2022-end.
- From 2018 to 2022, the market demand expanded at a CAGR of 4.3%.
- The market in India is expected to expand at a CAGR of 4.5% through 2033.
- By end-user, the hospitals segment to expand at a CAGR of 4.5% through 2033.
- From 2023 to 2033, neurointerventional devices market is expected to flourish at a CAGR of 4.7%.
- By 2033, the market value of neurointerventional devices is expected to reach US$ 4.1 billion.
“The digitalization of healthcare records and patient data can facilitate seamless communication between healthcare providers, potentially improving the utilization of neurointerventional devices,” remarks Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-871
Top Key Companies Profiled in the Neurointerventional Devices Market:
- Stryker Corporation
- Penumbra Inc.
- Covidien Public Limited
- Johnson & Johnson Private Limited
- Terumo Corporation
- Medtronic
- Boston Scientific
- MicroPort Scientific Corporation
- W. L. Gore & Associates, Inc.
- Abbott
- Philips Healthcare
- Siemens Healthineers
Recent Developments of the Neurointerventional Devices Market:
- In 2023, Johnson & Johnson announced the launch of its new neurointerventional device, the EmboTrap™ II Embolic Capture Device. The EmboTrap™ II Embolic Capture Device is a next-generation embolectomy device designed to improve stroke treatment.
- In 2022, Boston Scientific announced the launch of its new neurointerventional device, the ACURUN™ Onyx™ Liquid Embolic System. The ACURUN™ Onyx™ Liquid Embolic System is a liquid embolic agent designed to treat vascular malformations and other neurovascular disorders.
More Valuable Insights Available:
Future Market Insights offers an unbiased analysis of the global neurointerventional devices market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.
To understand opportunities in the neurointerventional devices market, the market is segmented based on product (embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy, embolic protection devices, flow diverters devices, intravascular devices, liquid embolic, balloons, and stent retrievers), technique (hospitals, and ambulatory surgical centers), and end-user (hospitals, and ambulatory surgical centers), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, and Middle East & Africa (MEA)
About the Healthcare Division at Future Market Insights:
The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With over 100+ reports and 1 Million+ data points, the team has analyzed the industry lucidly in 50+ countries for over a decade. The team briefly analyzes key trends, including competitive landscape, profit margin, and research development efforts.
Access Exclusive Market Insights - Purchase Now! https://www.futuremarketinsights.com/checkout/871
Segmentation Analysis of the Neurointerventional Device Market:
By Product:
- Embolic Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Embolic Protection Device
- Flow Diverters Device
- Intrasaccular Device
- Liquid Embolic
- Balloons
- Stent Retrievers
By Technique:
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
By End User:
- Hospitals
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at Related Reports Covered in Neurointerventional Device Market:
- Neurostimulation Market valuation is US$ 6,221.2 million in 2023. The neurostimulation market is expected to grow at a promising CAGR of 9.5% through 2033, with a forecast valuation of US$ 15,417.4 million by 2033.
- Neurodegenerative Disease Market is anticipated to register a CAGR of 7% during the forecast period, up from US$ 43.7 Billion in 2021 to reach a valuation of US$ 92 Billion by 2032.
- Portable Medical Devices Market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033
- Neurotrophic Keratitis Treatment Market is slated to reach a valuation of US$ 5 billion in 2023. According to Future Market Insights, the market is expected to grow at a 7.17% CAGR until 2033
- Neuroendocrine Carcinoma Treatment Market is set to record a market value of U.S$ 1.7 Bn in the year 2022 with a CAGR of 8.0% which indicates a positive market growth over the forecast period.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
